OBJECTIVE In this quality follow-up, adherence to GLP-1 receptor agonists was evaluated at 6, 12, and 18 months in patients receiving these medications within a comprehensive, digitally delivered weight management programme incorporating both medical treatment and intensive lifestyle intervention
While not directly associated with anemia in clinical trials, clinicians may consider individual patient factors when determining appropriate monitoring during treatment
Contact your GP or prescribing clinician if you experience cold intolerance accompanied by other symptoms that might suggest thyroid dysfunction, such as: Extreme fatigue or weakness that interferes with daily activities Unexplained weight gain or cessation of weight loss despite adherence to treatment Significant hair loss or changes in hair texture Persistent constipation unresponsive to usual measures Dry, flaky skin or changes in skin texture Muscle aches, cramps, or weakness Slowed heart rate Depression or significant mood changes Cognitive difficulties, including memory problems or difficulty concentrating These symptoms could indicate hypothyroidism , which requires investigation through thyroid function tests (TSH, free T4)
The most notable benefit patients receive from use of Semaglutide is significant weight loss in a short amount of time